Literature DB >> 31408558

Reduced handgrip strength is predictive of poor survival among patients with liver cirrhosis: A sex-stratified analysis.

Tatsunori Hanai1,2, Makoto Shiraki1, Kenji Imai1, Atsushi Suetsugu1, Koji Takai1,2, Hisataka Moriwaki1, Masahito Shimizu1.   

Abstract

AIM: Handgrip strength (HGS) is a marker of sarcopenia and has been used to stratify an individual's risk of death. We aimed to assess the prognostic significance of HGS in patients with liver cirrhosis.
METHODS: In this retrospective study, we collated data of 563 consecutive patients admitted to our hospital with cirrhosis (375 men). A dynamometer was used to measure HGS. Body composition (including skeletal muscle and adipose tissue volumes) was estimated using computed tomography. Predictors of mortality were identified using sex-stratified multivariate analyses.
RESULTS: After adjustments for age, cirrhosis etiology, Child-Pugh score, and other confounding variables, HGS, but not body composition, was independently associated with mortality in male patients (hazard ratio [HR], 0.96; 95% confidence interval [CI], 0.94-0.99; P < 0.01) and female patients (HR, 0.91; 95% CI, 0.84-0.99; P = 0.02). Men with low HGS (<30 kg) had a higher risk of mortality (HR, 2.09; 95% CI, 1.39-3.17; P < 0.001), as did women with low (<15 kg) HGS (HR, 2.14; 95% CI, 1.16-4.01; P = 0.02). We could stratify the sex-specific risk of mortality in cirrhotic patients using HGS, regardless of coexistent hepatocellular carcinoma and the Child-Pugh class.
CONCLUSIONS: Reduced HGS, rather than skeletal muscle and adipose tissue volumes, is associated with an increased risk of mortality in patients of both sexes with liver cirrhosis. Measurement of HGS is a simple, cost-effective, and appropriate bedside assessment for the prediction of survival in patients with cirrhosis.
© 2019 The Japan Society of Hepatology.

Entities:  

Keywords:  cirrhosis; handgrip strength; mortality; sarcopenia; skeletal muscle

Year:  2019        PMID: 31408558     DOI: 10.1111/hepr.13420

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  10 in total

1.  Predictors for Grip Strength Loss in Patients With Chronic Liver Diseases.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  Clinical Significance of Serum Zinc Levels on the Development of Sarcopenia in Cirrhotic Patients.

Authors:  Koji Murata; Tadashi Namisaki; Yuki Fujimoto; Soichi Takeda; Masahide Enomoto; Hiroaki Takaya; Yuki Tsuji; Akihiko Shibamoto; Junya Suzuki; Takahiro Kubo; Satoshi Iwai; Fumimasa Tomooka; Misako Tanaka; Miki Kaneko; Shohei Asada; Aritoshi Koizumi; Nobuyuki Yorioka; Takuya Matsuda; Takahiro Ozutsumi; Koji Ishida; Hiroyuki Ogawa; Hirotetsu Takagi; Yukihisa Fujinaga; Masanori Furukawa; Yasuhiko Sawada; Norihisa Nishimura; Koh Kitagawa; Shinya Sato; Kosuke Kaji; Takashi Inoue; Kiyoshi Asada; Hideto Kawaratani; Kei Moriya; Takemi Akahane; Akira Mitoro; Hitoshi Yoshiji
Journal:  Cancer Diagn Progn       Date:  2022-03-03

Review 3.  Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment.

Authors:  Takahiro Yamasaki; Issei Saeki; Yurika Yamauchi; Toshihiko Matsumoto; Yutaka Suehiro; Tomokazu Kawaoka; Shinsuke Uchikawa; Akira Hiramatsu; Hiroshi Aikata; Kazufumi Kobayashi; Takayuki Kondo; Sadahisa Ogasawara; Tetsuhiro Chiba; Taro Takami; Kazuaki Chayama; Naoya Kato; Isao Sakaida
Journal:  Liver Cancer       Date:  2022-02-22       Impact factor: 12.430

4.  Calf Circumference as a Useful Predictor of Sarcopenia in Patients With Liver Diseases.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

5.  Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker.

Authors:  Atsushi Hiraoka; Masaya Kato; Kaori Marui; Taisei Murakami; Kei Onishi; Tomoko Adachi; Junko Matsuoka; Hidetaro Ueki; Takeaki Yoshino; Miho Tsuruta; Toshihiko Aibiki; Tomonari Okudaira; Taira Kuroda; Ryuichiro Iwasaki; Yoshifumi Suga; Hideki Miyata; Tomoyuki Ninomiya; Masashi Hirooka; Masanori Abe; Bunzo Matsuura; Kojiro Michitaka; Yoichi Hiasa
Journal:  Cancer Med       Date:  2021-05-07       Impact factor: 4.452

6.  Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  Ann Transl Med       Date:  2021-04

7.  Controversies in Diagnosing Sarcopenia in Cirrhosis-Moving from Research to Clinical Practice.

Authors:  Marie Sinclair
Journal:  Nutrients       Date:  2019-10-14       Impact factor: 5.717

Review 8.  Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis.

Authors:  Hiroki Nishikawa; Hirayuki Enomoto; Shuhei Nishiguchi; Hiroko Iijima
Journal:  Int J Mol Sci       Date:  2020-07-24       Impact factor: 5.923

Review 9.  Definition of Sarcopenia in Chronic Liver Disease.

Authors:  Seong Wan Son; Do Seon Song; U Im Chang; Jin Mo Yang
Journal:  Life (Basel)       Date:  2021-04-16

10.  Muscle weakness assessment in non-hypoxemic COPD out-patients at tertiary care hospitals.

Authors:  Faisal Faiyaz Zuberi; Bader Faiyaz Zuberi; Faiza Sadaqat Ali; Nimrah Bader
Journal:  Pak J Med Sci       Date:  2021 Mar-Apr       Impact factor: 1.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.